Markers of fibrosis in ischemic chronic heart failure and renal dysfunction

Authors

  • V. D. Syvolap
  • D. A. Lashkul

DOI:

https://doi.org/10.14739/2310-1210.2015.3.44452

Keywords:

Heart Failure, Biomarkers, Fibrosis, Kidney

Abstract

Aim. Features of the extracellular matrix metabolism depending on the state of renal function were identified in 113 patients with ischemic chronic heart failure using ELISA, echocardiography.

Methods and results. Activity of collagen metabolism markers (MMP-9, TIMP-1, РІСР), cystatin C, structural and functional parameters of the heart were studied. It was established that the presence of moderate renal dysfunction in ischemic chronic heart failure was associated with age, history of myocardial infarction and hypertension, accompanied by the increasing of NT-proBNP, cystatin C, MMP-9 and was characterized by structural remodeling of the left atrium and ventricle with increased systolic pressure in the pulmonary artery, the deterioration of systolic and diastolic function.

References

Chen-Scarabelli, C., Saravolatz, L., Hirsh, B., Agrawal, P., & Scarabelli, T.M. (2015). Dilemmas in end-stage heart failure. J Geriatr Cardiol., 12(1), 57–65. doi: 10.11909/j.issn.1671-5411.2015.01.007.

Lee, D., Wilson, K., Akehurst, R., Cowie, M., Zannad, F., & Krum, H. et al. (2014). Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms. Heart, 100(21), 1681–1687. doi:10.1136/heartjnl-2014-305673.

Braunwald, E. (2013). Heart Failure. JACC: Heart Failure, 1(1), 1–20. doi:10.1016/j.jchf.2012.10.002

Takawale, A., Sakamuri, S.S., & Kassiri, Z. (2015). Extracellular matrix communication and turnover in cardiac physiology and pathology. Compr Physiol., 5(2), 687–719. doi: 10.1002/cphy.c140045.

Metra, M., Cotter, G., Gheorghiade, M., Dei Cas, L., & Voors, A. (2012). The role of the kidney in heart failure. European Heart Journal, 33(17), 2135–2142. doi:10.1093/eurheartj/ehs205.

Hundae, A., & McCullough, P. (2014). Cardiac and Renal Fibrosis in Chronic Cardiorenal Syndromes. Nephron Clinical Practice, 127(1–4), 106–112. doi:10.1159/000363705.

Voronkov, L. G., Amosova, K. M., Bahrii, A. E., Dziak, G. V., Diadyk, O.I ., Zharinov, O. Y., et al. (2012). Rekomendatsii z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti [Guidelines for the diagnosis and treatment of chronic heart failure]. Sertseva nedostatnist; 3, 60–96 [in Ukrainian].

(2013). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Suppl, 3, 1–150.

Sivasubramanian, N., Coker, M., Kurrelmeyer, K., MacLellan, W., DeMayo, F., Spinale, F., & Mann, D. (2001). Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor. Circulation, 104(7), 826–831. doi:10.1161/hc3401.093154.

Syvolap, V. D., & Lashkul, D. A. (2014). Vzaiemozviazky mizh rivnem markeriv fibrozu ST2, halektynu-3, strukturno-funktsionalnymy parametramy livoho shlunochka ta funktsiieiu nyrok pry khronichnii sertsevii nedostatnosti ishemichnoho genezu [The relationship between the level of markers of fibrosis ST2, galectin-3, structural, functional parameters of the left ventricle and renal function in patients with ischemic chronic heart failure]. Zaporozhskij medicinskij zhurnal, 5(86), 13–17 [in Ukrainian].

Radauceanu, A., Ducki, C., Virion, J., Rossignol, P., Mallat, Z., & McMurray, J. et al. (2008). Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure. Journal Of Cardiac Failure, 14(6), 467–474. doi:10.1016/j.cardfail.2008.02.014.

Kitaoka, H., Kubo, T., Okawa, M., Hayato, K., Yamasaki, N., Matsumura, Y., & Doi, Y. (2010). Impact of Metalloproteinases on Left Ventricular Remodeling and Heart Failure Events in Patients With Hypertrophic Cardiomyopathy. Circ J, 74(6), 1191–1196. doi:10.1253/circj.cj-09-1013.

Caron, A., Desrosiers, R., Langlois, S., & Béliveau, R. (2005). Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli. Revue Canadienne De Physiologie Et Pharmacologie, 83(3), 287–300. doi:10.1139/y05-011.

Covington, M. (2005). Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). AJP: Renal Physiology, 290(1), F43–F51. doi:10.1152/ajprenal.00179.2005.

Caron, A., Desrosiers, R., & Béliveau, R. (2005). Ischemia injury alters endothelial cell properties of kidney cortex: Stimulation of MMP-9. Experimental Cell Research, 310(1), 105–116. doi:10.1016/j.yexcr.2005.07.004.

Downloads

How to Cite

1.
Syvolap VD, Lashkul DA. Markers of fibrosis in ischemic chronic heart failure and renal dysfunction. Zaporozhye Medical Journal [Internet]. 2015Jun.15 [cited 2024Nov.22];17(3). Available from: http://zmj.zsmu.edu.ua/article/view/44452

Issue

No. 3 (2015): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)